Hollsteen
← Take-Two

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 FY2016: $527M · 10-Q 0001047469-15-006749 filed Aug 10, 2015Equity incl. NCI · Q2 FY2016: $564M · 10-Q 0001047469-15-008367 filed Nov 6, 2015Equity incl. NCI · Q3 FY2016: $527M · 10-Q 0001047469-16-010014 filed Feb 4, 2016Equity incl. NCI · Q4 FY2016: $581M · 10-K 0001628280-19-006691 filed May 14, 2019Equity incl. NCI · Q1 FY2017: −$41.0M · 10-Q 0001628280-17-007899 filed Aug 3, 2017Equity incl. NCI · Q2 FY2017: −$43.0M · 10-Q 0001628280-17-011117 filed Nov 8, 2017Equity incl. NCI · Q3 FY2017: −$48.0M · 10-Q 0001628280-18-001226 filed Feb 8, 2018Equity incl. NCI · Q4 FY2017: $1.0B · 10-K 0001628280-20-008291 filed May 22, 2020Equity incl. NCI · Q1 FY2018: −$38.0M · 10-Q 0001628280-17-007899 filed Aug 3, 2017Equity incl. NCI · Q2 FY2018: −$28.0M · 10-Q 0001628280-17-011117 filed Nov 8, 2017Equity incl. NCI · Q3 FY2018: −$31.0M · 10-Q 0001628280-18-001226 filed Feb 8, 2018Equity incl. NCI · Q4 FY2018: $1.5B · 10-K 0001628280-20-008291 filed May 22, 2020Equity incl. NCI · Q1 FY2019: $1.9B · 10-Q 0001628280-19-013731 filed Nov 8, 2019Equity incl. NCI · Q2 FY2019: $1.9B · 10-Q 0001628280-20-001155 filed Feb 7, 2020Equity incl. NCI · Q3 FY2019: $2.0B · 10-Q 0001628280-20-001155 filed Feb 7, 2020Equity incl. NCI · Q4 FY2019: $2.0B · 10-K 0001628280-20-008291 filed May 22, 2020Equity incl. NCI · Q1 FY2020: $2.1B · 10-Q 0001628280-19-013731 filed Nov 8, 2019Equity incl. NCI · Q2 FY2020: $2.2B · 10-Q 0001628280-20-001155 filed Feb 7, 2020Equity incl. NCI · Q3 FY2020: $2.4B · 10-Q 0001628280-20-001155 filed Feb 7, 2020Equity incl. NCI · Q4 FY2020: $2.5B · 10-K 0001628280-23-019851 filed May 26, 2023Equity incl. NCI · Q1 FY2021: $2.7B · 10-Q 0001628280-20-011493 filed Aug 4, 2020Equity incl. NCI · Q2 FY2021: $2.9B · 10-Q 0001628280-20-015824 filed Nov 6, 2020Equity incl. NCI · Q3 FY2021: $3.2B · 10-Q 0001628280-21-001632 filed Feb 9, 2021Equity incl. NCI · Q4 FY2021: $3.3B · 10-K 0001628280-21-010627 filed May 19, 2021Equity incl. NCI · Q1 FY2022: $3.6B · 10-Q 0001628280-22-028716 filed Nov 8, 2022Equity incl. NCI · Q2 FY2022: $3.5B · 10-Q 0001628280-22-028716 filed Nov 8, 2022Equity incl. NCI · Q3 FY2022: $3.7B · 10-Q 0001628280-23-002448 filed Feb 7, 2023Equity incl. NCI · Q4 FY2022: $3.8B · 10-K 0001628280-23-019851 filed May 26, 2023Equity incl. NCI · Q1 FY2023: $9.7B · 10-Q 0001628280-22-021685 filed Aug 9, 2022Equity incl. NCI · Q2 FY2023: $9.4B · 10-Q 0001628280-22-028716 filed Nov 8, 2022Equity incl. NCI · Q3 FY2023: $9.6B · 10-Q 0001628280-23-002448 filed Feb 7, 2023Equity incl. NCI · Q4 FY2023: $9.0B · 10-K 0001628280-23-019851 filed May 26, 2023Equity incl. NCI · Q1 FY2024: $8.9B · 10-Q 0001628280-23-028326 filed Aug 9, 2023Equity incl. NCI · Q2 FY2024: $8.4B · 10-Q 0001628280-23-037956 filed Nov 9, 2023Equity incl. NCI · Q3 FY2024: $8.5B · 10-Q 0001628280-24-003951 filed Feb 9, 2024Equity incl. NCI · Q4 FY2024: $5.7B · 10-K 0001628280-24-024623 filed May 22, 2024Equity incl. NCI · Q1 FY2025: $6.0B · 10-Q 0001628280-24-036273 filed Aug 9, 2024Equity incl. NCI · Q2 FY2025: $5.8B · 10-Q 0001628280-24-045867 filed Nov 7, 2024Equity incl. NCI · Q3 FY2025: $5.7B · 10-Q 0001628280-25-004308 filed Feb 7, 2025Equity incl. NCI · Q4 FY2025: $2.1B · 10-K 0001628280-25-026694 filed May 20, 2025Equity incl. NCI · Q1 FY2026: $3.5B · 10-Q 0001628280-25-038963 filed Aug 7, 2025Equity incl. NCI · Q2 FY2026: $3.4B · 10-Q 0001628280-25-050326 filed Nov 7, 2025Equity incl. NCI · Q3 FY2026: $3.5B · 10-Q 0001628280-26-005119 filed Feb 4, 2026Equity incl. NCI · Q4 FY2026: $3.5B · 10-K 0001628280-26-037434 filed May 22, 2026Equity incl. NCI · Q1 FY2027: $3.6B · 10-Q 0001628280-26-054870 filed Aug 7, 20263,5115279,662Q1 FY2016Q1 FY2027
$MEquity incl. NCI · Q2 FY2025: $5.8B · 10-Q 0001628280-24-045867 filed Nov 7, 2024Equity incl. NCI · Q3 FY2025: $5.7B · 10-Q 0001628280-25-004308 filed Feb 7, 2025Equity incl. NCI · Q4 FY2025: $2.1B · 10-K 0001628280-25-026694 filed May 20, 2025Equity incl. NCI · Q1 FY2026: $3.5B · 10-Q 0001628280-25-038963 filed Aug 7, 2025Equity incl. NCI · Q2 FY2026: $3.4B · 10-Q 0001628280-25-050326 filed Nov 7, 2025Equity incl. NCI · Q3 FY2026: $3.5B · 10-Q 0001628280-26-005119 filed Feb 4, 2026Equity incl. NCI · Q4 FY2026: $3.5B · 10-K 0001628280-26-037434 filed May 22, 2026Equity incl. NCI · Q1 FY2027: $3.6B · 10-Q 0001628280-26-054870 filed Aug 7, 20263,5115,798Q2 FY2025Q1 FY2027
Q4 FY2026
3,511$M
All values (45)
PeriodValue ($M)Status
Q1 FY20273,608reported
Q4 FY20263,511reported
Q3 FY20263,496reported
Q2 FY20263,432reported
Q1 FY20263,481reported
Q4 FY20252,138reported
Q3 FY20255,702reported
Q2 FY20255,798reported
Q1 FY20255,992reported
Q4 FY20245,668reported
Q3 FY20248,509reported
Q2 FY20248,430reported
Q1 FY20248,940reported
Q4 FY20239,042reported
Q3 FY20239,550reported
Q2 FY20239,434reported
Q1 FY20239,662reported
Q4 FY20223,810reported
Q3 FY20223,666reported
Q2 FY20223,470reported
Q1 FY20223,631reported
Q4 FY20213,332reported
Q3 FY20213,155reported
Q2 FY20212,901reported
Q1 FY20212,651reported
Q4 FY20202,539reported
Q3 FY20202,402reported
Q2 FY20202,182reported
Q1 FY20202,086reported
Q4 FY20192,041reported
Q3 FY20192,027reported
Q2 FY20191,944reported
Q1 FY20191,852reported
Q4 FY20181,489reported
Q3 FY2018−31reported
Q2 FY2018−28reported
Q1 FY2018−38reported
Q4 FY20171,004reported
Q3 FY2017−48reported
Q2 FY2017−43reported
Q1 FY2017−41reported
Q4 FY2016581reported
Q3 FY2016527reported
Q2 FY2016564reported
Q1 FY2016527reported

CSV with all sources · Technical ID: equity_total

More metrics for Take-Two

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$3.5B
Period
Q4 FY2026, ended Mar 31, 2026 · as of Mar 31, 2026 (balance as of date, not a sum)
Source
10-K, filed May 22, 2026 · 0001628280-26-037434
Location
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$3.5BMay 22, 202610-K 0001628280-26-037434reported · confidence 1. · current